Consistently, NAMPT 3′-UTR has been reported in a number of studies, as the potential target for a wide variety of miRNAs in other malignancies and diseases including miR-182 in the ossification of ligamentum flavum [35], miR-300 in neonatal sepsis [36], miR-34a in obesity [37], miR-206 in pancreatic cancer [38], miR-26b in colorectal cancer [39], miR-410 in pulmonary arterial hypertension (PAH) [40] and miR-182 in HIV-1 contaminated cells [41]. This evidence concerns the gene NAMPT and pancreatic neoplasm.